Wikipedia -WSS

Wikipedia

author：focus 2025-09-28 07:07:50 - browse：1693

Palm Drive at Stanford University on March 28, 2023 — Palm Drive at the entrance to Stanford University. Brian Frank for STAT

The resignation of Marc Tessier-Lavigne as president of Stanford University following an investigation into irregularities in his past research marks more than just the startling downfall of the leader of one of the nation’s top research powerhouses. The case is likely to have broader repercussions, signaling a tipping point in an ongoing and often contentious debate about how to assign blame and credit in the increasingly collaborative world of research.

Science is a team sport. And while the lab leaders, or principal investigators, often get most of the attention for biomedical breakthroughs, they seldom run experiments. That work is left to postdoctoral researchers, graduate students, and others who peer through microscopes, labor away in mouse rooms, and spend countless hours pipetting. Instead, professors play more of a managerial role, supervising, critiquing, and offering big-picture feedback on the work that goes on in their lab.

It’s a longstanding arrangement, but one that leads to a thorny question when research is challenged: Who’s to blame? STAT put that question to Stanford faculty and students while reporting earlier this year on allegations of image manipulation and other misconduct related to research in Tessier-Lavigne’s lab, as well as researchers at other institutions. The answer varied depending on whom you asked.

Graduate students stressed that since faculty have no qualms using work done in their labs to land grants, win prizes, and build prestige, they should ultimately be accountable for problems with the science done under their supervision. Faculty generally agree, at least in principle, but are often quick to say that there are limits to how closely they can scrutinize their lab’s work, and that team science is in part based on trust. It’s an argument Tessier-Lavigne cited in his own statement about his resignation.

It’s also one he said wasn’t good enough.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Readout Newsletter: Parkinson's study, Gilead, CG Oncology

explore

hotspot

WSS

Will biotech layoffs continue through 2023?

Marc Tessier

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

Update the Apgar Score to remove skin color

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

FDA endorses new sterilization method for medical devices

explore

Wikipedia

Wikipedia

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Inaction leaves children at risk from dangerous chemotherapy drug

How one medical school became remarkably diverse

What causes osteoarthritis? Researchers study link to brain protein

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Drug repurposing or repositioning? The language matters

An outrageous hospital charge: I paid $710 for an hour of babysitting

Drug repurposing or repositioning? The language matters

HPV vaccine, cervical cancer study delivers historic results

hotspot

VC firm RA Capital starts a new synthetic biology incubator

Medicare drug price lawsuits could be good politics for Biden

Public health communication lessons from Covid

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

Will biotech layoffs continue through 2023?

hotspot

explore

hotspot

knowledge